Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

NCT01339910 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

272

Enrollment

OTHER

Sponsor class

Stopped Accrual terminated as recommended by the data and safety monitoring board.

Conditions

Leukemia, Myelocytic, Acute

Interventions

DRUG: Fludarabine and Busulfan
DRUG: Fludarabine and Melphalan
DRUG: Busulfan and Fludarabine
DRUG: Busulfan and Cyclophosphamide
DRUG: Cyclophosphamide and Total Body Irradiation

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]